Open AccessWhich immunosuppressive drug is preferred in the treatment of toxic epidermal necrolysis during COVID‐19 outbreak?
Author(s) -
Farajzadeh Saeedeh,
Ahramiyanpour Najmeh
Publication year - 2021
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.4249
Subject(s) - toxic epidermal necrolysis , medicine , outbreak , covid-19 , dermatology , drug , intensive care medicine , pharmacology , virology , disease , infectious disease (medical specialty)
Cyclosporine is an effective and safe immunosuppressant in the management of Toxic epidermal necrolysis (TEN) during COVID‐19 outbreak for patients that intravenous immunoglobulin (IVIG) is contraindicated or is not affordable.